Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

American Airlines dials back profit guidance despite Q2 beat

(Sharecast News) - American Airlines dialled back profit guidance on Thursday despite beating on both the top and bottom lines with its Q2 trading performance. American Airlines guided to a FY25 adjusted loss per-share of as much as $0.20 or earnings of as much as $0.80, down from previous estimates of adjusted earnings between $1.70 and $2.70 per share made back in January.

As far as Q3 was concerned, American now expects to report an adjusted per-share loss of $0.10 to $0.60.

For the three months ended 30 June, American said passenger revenue per available domestic seat mile was down more than 6%, while it was up nearly 3% for international as Americans continued to flock to the likes of Japan and Italy.

Q2 revenue rose 0.4% to $14.39bn, ahead of expectations, while net income dropped 16.5% to $599.0m, or $0.91 per share. Adjusting for one-time items, American reported earnings of $628.0m, well ahead of expectations on the Street.

As of 1540 BST, American Airlines shares were down 7.93% at $11.68 each.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.